Clinical Trial Update: Study of Ruxolitinib in Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of ruxolitinib in colorectal cancer was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: CRC (Colorectal Cancer) | Phase 2 | Status: TERMINATED | Results posted: 2017-06-14